Morgan Stanley Lifts UnitedHealth Group Target to $468 as EPS Guidance Tops $18.25
UNH•UnitedHealth Group secured an “Overweight” rating and saw its price target raised to $468 by Morgan Stanley on June 30, reflecting analyst confidence. The company’s first-quarter medical care ratio fell to 83.9% and management lifted full-year 2026 adjusted earnings guidance to over $18.25 per share.
1. Analyst Rating Upgrade
On June 30, Morgan Stanley reaffirmed an Overweight rating on UnitedHealth Group and raised its twelve-month price target from $453 to $468, signaling increased confidence in the company’s growth prospects.
2. Cost Management Improvement
UnitedHealth Group’s first-quarter medical care ratio improved to 83.9% from 84.8% a year earlier, underscoring effective cost controls on medical claims.
3. Raised Earnings Forecast
Following stronger-than-expected quarterly results, management lifted its full-year 2026 adjusted earnings guidance to above $18.25 per share, up from prior estimates.
4. Stock Performance Momentum
The stock has rallied roughly 80% over recent months, formed a golden cross pattern, and reached a near four-month high around $420.
Related News
Sources
Up by 80%, does the UnitedHealth Group have more upside?
Invezz
UnitedHealth Group (NYSE: UNH) Stock Shows Strength Amid Positive Analyst Outlook and Strong Financials
Financialmodelingprep
